Aspirin induced apoptosis in gastric cancer cells

Biomedicine and Pharmacotherapy

Volumn 53, Issue 7, 1999, Pages 315-318

  Wong, B C Y ^a   Zhu, G H ^a   Lam, S K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Aspirin; Cyclooxygenase; Gastric cancer

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONE; SULINDAC;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; STOMACH CANCER;

EID: 0033178151     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(00)88503-0     Document Type: Article

References (32)

1. Kerr JFR, Willie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26: 1790-4.
2. Wyllie AH. Apoptosis (the 1992 Frank Ross memorial lecture). Br J Cancer 1993; 67: 205-8.
3. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994; 76: 777-9.
4. Williams GT. Programmed cell death: Apoptosis and oncogenesis. Cell 1991; 65: 1097-8.
5. Gorman AM, McGowan A, O'Neill C, Cotter T. Oxidative stress and apoptosis in neurodegeneration. J Neurol Sci 1996; 139 Suppl: 45-52.
6. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature (New Biol) 1971; 231: 232-5.
7. Vane JR. Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, et al. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci USA 1994; 91: 2046-50.
8. Miyamoto T, Ogino N, Yamamoto S, Hayaishi O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem 1976; 251: 2629-36.
9. Simmons DL, Levy DB, Yannoni Y, Erikson RL. Identification of a phorbol ester-repressible v-src-inducible gene. Proc Natl Acad Sci USA 1989; 86: 1178-82.
10. Dubois RN, Eberhart CE, Williams CS. Introduction to eicosanoids and the gastroenteric tract. Gastroenterol Clin North Am 1996; 25: 267-77.
11. Shimokawa T, Smith WL. Prostaglandin endoperoxide synthase. The aspirin acetylation region. J Biol Chem 1992; 267: 12387-92.
12. Lecomte M, Laneuville O, Ji C, DeWitt DL, Smith WL. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 1994; 269: 13207-15.
13. Mitchell JR, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90: 11693-7.
14. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610-4.
15. Pollard M, Luckert PH. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 1981; 214: 558-9.
16. Reddy BS, Rao CV, Rivenson A, Kelloff G. Inhibitory effects of aspirin on azoxymethane-induced colon carcinogenesis in F344rats. Carcinogenesis 1993; 14: 1493-7.
17. Rubio CA. Anti-tumoral activity of indomethacin in experimental esophageal tumors. J Natl Cancer Inst 1984; 72: 705-7.
18. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313-6.
19. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations and medications: Case-control results from the Melbourne colorectal cancer study. Cancer Res 1988; 48: 4399-04.
20. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: Non-steroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst 1991: 83: 355-8.
21. Peleg II, Maibach HT, Brown SH, Wilcox CM. Aspirin and non-steroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 1994; 154: 394-9.
22. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW. Aspirin use and risk of fatal cancer. Cancer Res 1993; 53: 1322-7.
23. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85: 307-11.
24. Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978; 31: 691-6.
25. Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, Finn T, et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 1997; 57: 2909-15.
26. Elder DJ, Hague A, Hicks DJ, Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res 1996; 56: 2273-6.
27. Shiff SJ, Qiao L, Tsai LL, Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induce apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 1995; 96: 491-503.
28. Goldberg Y, Nassif H, Pittas A, Tsai LL, Dynlacht BD, Rigas B, et al. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene 1996; 12: 893-901.
29. Zhu GH, Wong BCY, Eggo MC, Ching CK, Yuen ST, Chan EYT, Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc. Br J Cancer 1999: 79; 393-400.
30. Piazza GA, Kulchak-Rahm AL, Krutzch M, Sperl G, Paranka NS, Gross PH, et al. Anti-neoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 1995; 55: 3110-6.
31. Zhu GH, Wong BCY, Ching CK, Lai KC, Lam SK. Differential apoptosis in gastric epithelial cells through the constitutive expression of wild-type p53 and/or up-regulation of c-myc. Biochem Pharmacol 1999; 58: 193-200.
32. Zhu GH, Wong BCY, Eggo MC, Yuen ST, Lai KC, Lam SK. Pharmacological inhibition of protein kinase C activity could induce apoptosis in gastric cancer cells by differential regulation of apoptosis-related genes. Dig Dis Sci 1999, in press.